| Medical Center Of East Hartford Llc | |
|
580 Burnside Ave Ste 2 East Hartford CT 06108-3579 | |
| (860) 816-3231 | |
| Not Available |
| Full Name | Medical Center Of East Hartford Llc |
|---|---|
| Speciality | General Practice |
| Location | 580 Burnside Ave Ste 2, East Hartford, Connecticut |
| Authorized Official Name and Position | Anum Sheikh Ahmed (OWNER) |
| Authorized Official Contact | 8602638266 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Medical Center Of East Hartford Llc 580 Burnside Ave Ste 2 East Hartford CT 06108-3579 Ph: (860) 263-8266 | Medical Center Of East Hartford Llc 580 Burnside Ave Ste 2 East Hartford CT 06108-3579 Ph: (860) 816-3231 |
| NPI Number | 1811514292 |
|---|---|
| Provider Enumeration Date | 07/01/2020 |
| Last Update Date | 02/25/2021 |
| Medicare PECOS PAC ID | 3870919822 |
|---|---|
| Medicare Enrollment ID | O20200820002519 |
News Archive
To address this gap, researchers from the U.S. evaluated the timing of antibody production against SARS-CoV-2 in hospitalized patients. They used a highly sensitive multiplexed bead-based immunoassay that allows for early detection of anti-SARS-CoV-2 antibodies. The study is published on the preprint server medRxiv.
Bristol-Myers Squibb Company is commencing today, through its wholly owned subsidiary B&R Acquisition Company, a cash tender offer to purchase all outstanding shares of common stock of Amylin Pharmaceuticals, Inc.
QuadraMed Corporation is pleased to announce the General Availability of the next major version of its enterprise EHR solution, QuadraMed Computerized Patient Record. QCPR version 6.0 provides key capabilities and improvements that help organizations provide high-quality and efficient care; meet pressing Canadian, as well as U.S. governmental and industry regulations; and deliver better patient safety, patient engagement, data security, and privacy while being fully interoperable.
Mitch DeKoven, Director, HEOR, Real-World Evidence Solutions, IMS Health Inc. and Won Chan Lee, Ph.D., Principal, Health Economics and Outcomes Research, IMS Health, Inc. will present Optimizing Strategic Direction with Systematic Value Development at the Pharmaceutical Market Access Pricing and Reimbursement Conference in San Francisco on October 29, 2013.
Shire plc, the global specialty biopharmaceutical company, announced today that it will present key scientific data on its Attention-Deficit/Hyperactivity Disorder (ADHD) treatments, INTUNIV(TM) (guanfacine) Extended Release Tablets, Vyvanse®( ) (lisdexamfetamine dimesylate) Capsules CII, and Daytrana®( ) (methylphenidate transdermal system) CII, at a national meeting of psychiatrists to be held October 27 - November 1 in Honolulu.
› Verified 1 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1811514292 | NPI | - | NPPES |
| Provider Name | Anum Ahmed |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1396191797 PECOS PAC ID: 8325385784 Enrollment ID: I20200820003125 |
News Archive
To address this gap, researchers from the U.S. evaluated the timing of antibody production against SARS-CoV-2 in hospitalized patients. They used a highly sensitive multiplexed bead-based immunoassay that allows for early detection of anti-SARS-CoV-2 antibodies. The study is published on the preprint server medRxiv.
Bristol-Myers Squibb Company is commencing today, through its wholly owned subsidiary B&R Acquisition Company, a cash tender offer to purchase all outstanding shares of common stock of Amylin Pharmaceuticals, Inc.
QuadraMed Corporation is pleased to announce the General Availability of the next major version of its enterprise EHR solution, QuadraMed Computerized Patient Record. QCPR version 6.0 provides key capabilities and improvements that help organizations provide high-quality and efficient care; meet pressing Canadian, as well as U.S. governmental and industry regulations; and deliver better patient safety, patient engagement, data security, and privacy while being fully interoperable.
Mitch DeKoven, Director, HEOR, Real-World Evidence Solutions, IMS Health Inc. and Won Chan Lee, Ph.D., Principal, Health Economics and Outcomes Research, IMS Health, Inc. will present Optimizing Strategic Direction with Systematic Value Development at the Pharmaceutical Market Access Pricing and Reimbursement Conference in San Francisco on October 29, 2013.
Shire plc, the global specialty biopharmaceutical company, announced today that it will present key scientific data on its Attention-Deficit/Hyperactivity Disorder (ADHD) treatments, INTUNIV(TM) (guanfacine) Extended Release Tablets, Vyvanse®( ) (lisdexamfetamine dimesylate) Capsules CII, and Daytrana®( ) (methylphenidate transdermal system) CII, at a national meeting of psychiatrists to be held October 27 - November 1 in Honolulu.
› Verified 1 days ago
News Archive
To address this gap, researchers from the U.S. evaluated the timing of antibody production against SARS-CoV-2 in hospitalized patients. They used a highly sensitive multiplexed bead-based immunoassay that allows for early detection of anti-SARS-CoV-2 antibodies. The study is published on the preprint server medRxiv.
Bristol-Myers Squibb Company is commencing today, through its wholly owned subsidiary B&R Acquisition Company, a cash tender offer to purchase all outstanding shares of common stock of Amylin Pharmaceuticals, Inc.
QuadraMed Corporation is pleased to announce the General Availability of the next major version of its enterprise EHR solution, QuadraMed Computerized Patient Record. QCPR version 6.0 provides key capabilities and improvements that help organizations provide high-quality and efficient care; meet pressing Canadian, as well as U.S. governmental and industry regulations; and deliver better patient safety, patient engagement, data security, and privacy while being fully interoperable.
Mitch DeKoven, Director, HEOR, Real-World Evidence Solutions, IMS Health Inc. and Won Chan Lee, Ph.D., Principal, Health Economics and Outcomes Research, IMS Health, Inc. will present Optimizing Strategic Direction with Systematic Value Development at the Pharmaceutical Market Access Pricing and Reimbursement Conference in San Francisco on October 29, 2013.
Shire plc, the global specialty biopharmaceutical company, announced today that it will present key scientific data on its Attention-Deficit/Hyperactivity Disorder (ADHD) treatments, INTUNIV(TM) (guanfacine) Extended Release Tablets, Vyvanse®( ) (lisdexamfetamine dimesylate) Capsules CII, and Daytrana®( ) (methylphenidate transdermal system) CII, at a national meeting of psychiatrists to be held October 27 - November 1 in Honolulu.
› Verified 1 days ago
M. Hasan Yekta, M.d. P.c. Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 27 Burnside Ave, East Hartford, CT 06108 Phone: 860-528-7161 | |
Family Medicine Center At East Hartford Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 775 Main St, East Hartford, CT 06108 Phone: 860-528-2138 Fax: 860-528-0514 | |
Silver Lane Medical Group Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 677 Silver Ln, East Hartford, CT 06118 Phone: 860-568-7243 Fax: 860-895-8107 | |
Dilligence Training Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 275 Park Ave, East Hartford, CT 06108 Phone: 860-292-0068 | |
First Choice Health Centers, Inc. Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 478 Burnside Ave, East Hartford, CT 06108 Phone: 860-610-6183 | |
First Choice Health Centers, Inc. Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 809 Main Street, East Hartford, CT 06108 Phone: 860-610-6131 Fax: 860-290-4142 | |
Pediatric & Adolescent Medicine Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 580 Burnside Ave, Suite 3, East Hartford, CT 06108 Phone: 860-282-7128 Fax: 860-646-1261 |